Page Tools:

Adult Metabolic and Cardiovascular Screening and Monitoring Form

Author(s): John W. Newcomer, MD, Gregory B. Couch Professor of Psychiatry, Psychology, & Medicine, Director, Clinical Trials Unit, Director, Regulartory Support Center, Institute of Clinical and Translational Sciences (ICTS), Medical Director, Center for Clinical Studies, Washington University School of Medicine, St. Louis, Missouri
Dan W. Haupt, MD, Assistant Professor of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, Assistant Director, Barnes Jewish Hospital Outpatient Psychiatry Clinic, St. Louis, Missouri
Details:
  • ISBN-13: 9780763799311
  • Tearsheets    48 pages      © 2011
Price: International Sales $35.95 US List

Overview

BULK ORDERS ONLY - MINIMUM OF 500
To order, please contact
Corporate Sales:                                Pharma Solutions:
Linda McGarvey                                  Contact our PHARMALink Team
lmcgarvey@jblearning.com
 

The Adult Metabolic and Cardiovascular Screening and Monitoring Form is a compiled instrument based on ADA and NCEP guidelines developed to help busy clinicians screen and monitor key metabolic variables for overweight and obesity as well as obesity-related conditions such as hyperglycemia, dyslipidemia, and hypertension in adults.  The form features management and treatment intervention recommendations, lab value fields for up to four different dates, a BMI table, checklists for cardiovascular disease (CVD) and diabetes risk factors and progress monitoring for:

  • Obesity
  • Dyslipidemia
  • Diabetic Risk
  • Hypertension
  • Smoking
     

 

ShowAbout the Author(s)

John W. Newcomer, MD-Gregory B. Couch Professor of Psychiatry, Psychology, & Medicine, Director, Clinical Trials Unit, Director, Regulartory Support Center, Institute of Clinical and Translational Sciences (ICTS), Medical Director, Center for Clinical Studies, Washington University School of Medicine, St. Louis, Missouri

John W. Newcomer, MD, is Professor of Psychiatry, Psychology and Medicine at Washington University School of Medicine in St. Louis. He is also the Medical Director for the Center for Clinical Studies at Washington University. Dr. Newcomer is a Principal Investigator on research grants funded through the National Institutes of Health (NIH), and also serves as the Chairman of the Drug Utilization Review (Medicaid) Board for the State of Missouri. 

Dr. Newcomer has received a number of honors and awards, including a 1999 Exemplary Psychiatrist Award from the National Alliance for the Mentally Ill (NAMI), an Independent Scientist Award from the National Institute of Mental Health (NIMH), and a 2002 Gerald L. Klerman Award for Outstanding Clinical Research from the National Alliance for Research on Schizophrenia and Depression (NARSAD). Funded continuously by the NIH for 14 years, Dr. Newcomer also serves as a reviewer for the NIH as well as other funding agencies, including the Department of Veteran’s Affairs and the National Science Foundation.

Dr. Newcomer serves on the editorial board for Neuropsychopharmacology, Journal of Clinical Psychiatry and the Journal of Psychotic Disorders, and he is a reviewer for numerous journals, including the New England Journal of Medicine, American Journal of Physiology, American Journal of Psychiatry, Archives of General Psychiatry, and the Journal of Neuroscience. He has contributed numerous articles to leading scientific journals, including Archives of General Psychiatry, The Journal of Clinical Endocrinology & Metabolism, The Journal of Neuroscience, and Neuropsychopharmacology.

Additional Titles by this Author

Dan W. Haupt, MD-Assistant Professor of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, Assistant Director, Barnes Jewish Hospital Outpatient Psychiatry Clinic, St. Louis, Missouri

Dan W. Haupt, MD is an Assistant Professor of Psychiatry at Washington University School of Medicine in St. Louis, and is an Assistant Director for the Barnes Jewish Hospital Outpatient Psychiatry Clinic. He is the recipient of a National Institute of Mental Health Career Development Award studying the metabolic effects of polypharmacy in schizophrenia. He is the recipient of two Young Investigator Awards from the National Alliance for Research on Schizophrenia and Depression (NARSAD), and was also named as a 2002 Lieber Investigator by NARSAD. In addition, he is a collaborator on other National Institutes of Health (NIH) funded studies of neuroendocrinology, including medication effects on glucose and lipid metabolism and adiposity.

He is actively involved in teaching, supervision of residents and medical students, and clinical care. He has served as a reviewer for more than 25 journals in the fields of psychiatry, neuroscience, and endocrinology, including the Archives of General Psychiatry, the American Journal of Psychiatry, and the New England Journal of Medicine. He also serves as a grant reviewer for the NIH. He has contributed articles as an author and coauthor to leading scientific journals, including the Archives of General Psychiatry and Neuropsychopharmacology.

Back to top